The level also the oxidation status and the multimeric pattern of this protein are associated with thrombotic vasculopathies. Recently, in an elegant study, Fu et al. have demonstrated that shear stress?induced unfolding of VWF exposes buried, oxidation-sensitive methionine residues, including Met1606, contained in the A1 and A2 VWF domain [32]. Conversion into methionine sulfoxide of these Met residues, buy PS-1145 buried in the coiled VWF conformation, is strongly facilitated by shear stress nduced unfolding of VWF multimers. Notably, methionine oxidation, besides reduced proteolysis by ADAMTS-13, results also in enhanced VWF binding to GpIb and platelet activation [5,32]. In addition, basic biophysical principles indicate that the higher the molecular size of the VWF, the higher is the sensitivity to shear stress [33]. Several studies have provided compelling evidence of the relevance of VWF levels in the pathogenesis of macrovascular thrombosis, especially in the brain circulation [34?6]. The findings of the present study emphasize also the relevance of the multimeric structure and especially of the oxidation status of VWF multimers for their pro-thrombotic effects. This phenomenon, along with thedocumented intrinsic hyperactivity of platelets in type 2 diabetic patients [37,38], can contribute to intensified adhesion, activation, and aggregation of platelets, favoring the occurrence of thrombotic complications in the arterial circulation. VWF has also other extra-haemostatic functions, including angiogenesis and leukocyte extravasation [39,40], which can cooperate in inducing thrombotic events. The BI-78D3 custom synthesis effect of VWF oxidation on these biological functions is still unknown and needs to be investigated to assess its possible contribution to these phenomena. This study has several clinical implications and limits. The results of this pilot study would indicate the need of prospective and intervention studies on diabetic population to correlate the progression of oxidative modification of VWF with major adverse cardiovascular events and their pharmacological prevention. The use of aspirin for the primary prevention of cardiovascular events in diabetic individuals is a widely recommended practice in accordance with existing guidelines [41]. However, several prospective trials have shown that in diabetic patients this drug shows a lower efficacy in protecting against thrombotic macroangiopathies than in not diabetic subjects [42?4]. This is likely a multifactorial phenomenon. However, it can be speculated that the lower pharmacological efficacy may be in part linked to lack of specificity of aspirin in inhibiting the VWF-platelet receptor interaction and signaling [45]. The use of novel anti-platelet agents as the inhibitors of the VWF-GpIb interaction [46?9] may ameliorate the outcome of antithrombotic therapy in T2-DM patients. Prospective studies are needed to assess whether the association of oxidative stress and VWF abnormalities is only a sustained epiphenomenon of thrombotic diseases or is causally related to macroangiopathic complications in diabetic patients. This conclusion cannot be unequivocally validated by the present study, since it is based on a post hoc analysis. Further work on the specificity and sensitivity of VWF:act and VWF-bound carbonyl level is therefore required to ascertain their role as prognostic biomarkers for thrombotic vasculopathies in type 2 diabetes mellitus. Even without a specific quantification of VWF-bound carbonyl.The level also the oxidation status and the multimeric pattern of this protein are associated with thrombotic vasculopathies. Recently, in an elegant study, Fu et al. have demonstrated that shear stress?induced unfolding of VWF exposes buried, oxidation-sensitive methionine residues, including Met1606, contained in the A1 and A2 VWF domain [32]. Conversion into methionine sulfoxide of these Met residues, buried in the coiled VWF conformation, is strongly facilitated by shear stress nduced unfolding of VWF multimers. Notably, methionine oxidation, besides reduced proteolysis by ADAMTS-13, results also in enhanced VWF binding to GpIb and platelet activation [5,32]. In addition, basic biophysical principles indicate that the higher the molecular size of the VWF, the higher is the sensitivity to shear stress [33]. Several studies have provided compelling evidence of the relevance of VWF levels in the pathogenesis of macrovascular thrombosis, especially in the brain circulation [34?6]. The findings of the present study emphasize also the relevance of the multimeric structure and especially of the oxidation status of VWF multimers for their pro-thrombotic effects. This phenomenon, along with thedocumented intrinsic hyperactivity of platelets in type 2 diabetic patients [37,38], can contribute to intensified adhesion, activation, and aggregation of platelets, favoring the occurrence of thrombotic complications in the arterial circulation. VWF has also other extra-haemostatic functions, including angiogenesis and leukocyte extravasation [39,40], which can cooperate in inducing thrombotic events. The effect of VWF oxidation on these biological functions is still unknown and needs to be investigated to assess its possible contribution to these phenomena. This study has several clinical implications and limits. The results of this pilot study would indicate the need of prospective and intervention studies on diabetic population to correlate the progression of oxidative modification of VWF with major adverse cardiovascular events and their pharmacological prevention. The use of aspirin for the primary prevention of cardiovascular events in diabetic individuals is a widely recommended practice in accordance with existing guidelines [41]. However, several prospective trials have shown that in diabetic patients this drug shows a lower efficacy in protecting against thrombotic macroangiopathies than in not diabetic subjects [42?4]. This is likely a multifactorial phenomenon. However, it can be speculated that the lower pharmacological efficacy may be in part linked to lack of specificity of aspirin in inhibiting the VWF-platelet receptor interaction and signaling [45]. The use of novel anti-platelet agents as the inhibitors of the VWF-GpIb interaction [46?9] may ameliorate the outcome of antithrombotic therapy in T2-DM patients. Prospective studies are needed to assess whether the association of oxidative stress and VWF abnormalities is only a sustained epiphenomenon of thrombotic diseases or is causally related to macroangiopathic complications in diabetic patients. This conclusion cannot be unequivocally validated by the present study, since it is based on a post hoc analysis. Further work on the specificity and sensitivity of VWF:act and VWF-bound carbonyl level is therefore required to ascertain their role as prognostic biomarkers for thrombotic vasculopathies in type 2 diabetes mellitus. Even without a specific quantification of VWF-bound carbonyl.
Interleukin Related interleukin-related.com
Just another WordPress site